DrHaritha Krishna Sudhakar

Haritha Krishna Sudhakar completed her PhD under the supervision of A/Prof. Yu Heng Lau at the University of Sydney exploring bicyclic peptide therapeutic leads against protein targets that function at telomeres.  Her expertise lies in organic synthetic chemistry, with a particular focus on solid-phase peptide synthesis.

Haritha is currently a postdoctoral researcher in the School of Medical Sciences at the University of Sydney, working with Professor Rachel Codd. Her research leads the development of chemistry, manufacturing, and controls (CMC) strategies for established and novel radiopharmaceutical chelator systems.